Geode Capital Management, LLC Clearside Biomedical, Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 764,058 shares of CLSD stock, worth $825,182. This represents 0.0% of its overall portfolio holdings.

Number of Shares

764,058

Previous 731,386 4.47%

Holding current value

$825,182

Previous $928,000 17.67%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$0.87 - $1.58 $28,424 - $51,621	32,672 Added 4.47%	764,058 $764,000
Q3 2024 Nov 12, 2024	BUY	$0.93 - $1.35 $54,952 - $79,770	59,089 Added 8.79%	731,386 $928,000
Q2 2024 Aug 09, 2024	BUY	$1.08 - $1.58 $32,490 - $47,532	30,084 Added 4.68%	672,297 $873,000
Q1 2024 May 13, 2024	BUY	$1.2 - $2.02 $181,827 - $306,076	151,523 Added 30.88%	642,213 $982,000
Q3 2023 Nov 13, 2023	SELL	$0.82 - $1.27 $6,983 - $10,816	-8,517 Reduced 1.71%	490,690 $426,000
Q2 2023 Aug 11, 2023	SELL	$0.97 - $1.48 $29,963 - $45,717	-30,890 Reduced 5.83%	499,207 $559,000
Q4 2022 Feb 13, 2023	BUY	$1.0 - $1.5 $4,790 - $7,185	4,790 Added 0.91%	530,097 $593,000
Q3 2022 Nov 14, 2022	BUY	$1.08 - $1.83 $1,421 - $2,408	1,316 Added 0.25%	525,307 $593,000
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.49 $44,280 - $84,814	34,062 Added 6.95%	523,991 $770,000
Q1 2022 May 13, 2022	BUY	$1.35 - $2.88 $4,437 - $9,466	3,287 Added 0.68%	489,929 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$4.83 - $7.2 $304,777 - $454,327	63,101 Added 14.9%	486,642 $2.92 Million
Q2 2021 Aug 13, 2021	BUY	$2.32 - $5.38 $136,457 - $316,440	58,818 Added 16.13%	423,541 $2.06 Million
Q1 2021 May 12, 2021	BUY	$2.24 - $4.25 $86,302 - $163,744	38,528 Added 11.81%	364,723 $900,000
Q1 2020 May 14, 2020	BUY	$1.32 - $3.77 $66,211 - $189,103	50,160 Added 18.17%	326,195 $554,000
Q4 2019 Feb 13, 2020	BUY	$0.62 - $3.4 $19,130 - $104,910	30,856 Added 12.59%	276,035 $800,000
Q3 2019 Nov 12, 2019	SELL	$0.59 - $1.32 $477 - $1,067	-809 Reduced 0.33%	245,179 $154,000
Q2 2019 Aug 14, 2019	SELL	$0.97 - $1.42 $71,393 - $104,514	-73,602 Reduced 23.03%	245,988 $239,000
Q1 2019 May 14, 2019	BUY	$1.1 - $1.74 $17,685 - $27,975	16,078 Added 5.3%	319,590 $441,000
Q4 2018 Feb 13, 2019	BUY	$1.0 - $6.12 $14,181 - $86,787	14,181 Added 4.9%	303,512 $324,000
Q3 2018 Nov 13, 2018	BUY	$6.03 - $11.24 $86,168 - $160,619	14,290 Added 5.2%	289,331 $1.78 Million
Q2 2018 Aug 14, 2018	BUY	$8.91 - $14.54 $286,919 - $468,217	32,202 Added 13.26%	275,041 $2.94 Million
Q1 2018 May 15, 2018	BUY	$5.57 - $14.28 $629,365 - $1.61 Million	112,992 Added 87.02%	242,839 $2.61 Million
Q4 2017 Feb 13, 2018	BUY	$5.78 - $9.12 $21,738 - $34,300	3,761 Added 2.98%	129,847 $908,000
Q3 2017 Nov 14, 2017	BUY	$6.73 - $8.74 $20,196 - $26,228	3,001 Added 2.44%	126,086 $1.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	123,085	123,085 $1.12 Million

Others Institutions Holding CLSD

# of Institutions

Shares Held

11.6M

Call Options Held

24K

Put Options Held

12.1K

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $65M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Clearside Biomedical, Inc. Transaction History